Bulletin
Investor Alert

New York Markets Open in:

May 21, 2021, 5:41 a.m. EDT

How to Improve The Timing of Investment Decisions in Cvs Health Corp CVS

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    CVS Health Corp. (CVS)

or Cancel Already have a watchlist? Log In

May 21, 2021 (Stock Traders Daily via COMTEX) -- Some people say that #timing does not matter, but it does. If you were to #buyandholdCvs Health Corp /zigman2/quotes/209664499/composite CVS -0.41% at a high, see it fall, and not be able to buy more on the dip like the big boys can, that would be troubling. Over time, Stock Traders Daily has found a way to lessen the odds of this happening. Below, we provide data for CVS that can be used to help achieve this goal. The data can be used to improve the timing of buy and sell decisions. This data was current at the time of publication, but it is not updated in real time here. If you want real time updates, or data on a different stock, please get one here Unlimited Real Time Reports .

Technical Summary

Our Longer Term Plans for CVS help you determine where to buy, sell, short, and set risk controls. Use this in conjunction with our Longer Term Market Analysis to go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis and see how it helps you work with this CVS Report.

Buy over 81.96 target n/a stop loss @ 81.72.

NONE .

COMTEX_387004429/2570/2021-05-21T05:41:06

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/209664499/composite
US : U.S.: NYSE
$ 83.30
-0.34 -0.41%
Volume: 3.28M
July 28, 2021 4:00p
P/E Ratio
14.83
Dividend Yield
2.40%
Market Cap
$110.12 billion
Rev. per Employee
$895,513
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.